Home / Health / Vaccine Panel May Delay Infant Hepatitis B Shot
Vaccine Panel May Delay Infant Hepatitis B Shot
2 Dec
Summary
- Advisers may delay routine hepatitis B shots for newborns.
- Concerns raised about vaccine ingredients like aluminum salts.
- Potential shift away from combination vaccines for single doses.
Advisers to Health Secretary Robert F. Kennedy Jr. are poised to enact substantial changes to the standard childhood vaccination schedule. A key proposal involves delaying the hepatitis B vaccine for newborns, a shot routinely given at birth. The committee is also expected to debate significant alterations to the timing and administration of other childhood immunizations, including a potential move towards single-dose vaccines instead of current combination products.
These potential modifications stem from long-held views by Mr. Kennedy and some panelists regarding vaccine safety and necessity, particularly concerning ingredients like aluminum salts and the perceived overload on infant immune systems. While not legally binding, the committee's decisions carry significant weight for insurance coverage and public health policy, potentially influencing vaccine confidence among Americans.
The discussions come amid broader debates about vaccine safety, with some officials questioning the administration of multiple vaccines concurrently. Public health experts and a coalition of Democratic governors are urging adherence to rigorous scientific evidence as the committee deliberates on guidelines that affect families, providers, and immunization systems nationwide.
